Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor

scientific article

Structural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1074/JBC.M111.261404
P3181OpenCitations bibliographic resource ID4330269
P932PMC publication ID3173127
P698PubMed publication ID21685390

P50authorDenis ServentQ46913748
P2093author name stringAndré Ménez
Bernard Gilquin
Elodie Marcon
Gilles Mourier
Sophie Zinn-Justin
Catherine Marquer
Carole Fruchart-Gaillard
Guillaume Letellier
P2860cites workThe structural basis for agonist and partial agonist action on a β(1)-adrenergic receptorQ24594844
Structure of a nanobody-stabilized active state of the β(2) adrenoceptorQ24597139
GPCRDB: information system for G protein-coupled receptorsQ24616648
Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonistsQ24619974
Structure and function of an irreversible agonist-β(2) adrenoceptor complexQ24620291
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonistQ24654563
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptorQ24657484
Structural response to mutation at a protein-protein interfaceQ27617450
Motions and structural variability within toxins: Implication for their use as scaffolds for protein engineeringQ27640337
Crystal structure of the human beta2 adrenergic G-protein-coupled receptorQ27648868
Structure of a beta1-adrenergic G-protein-coupled receptorQ27651011
Different interactions between MT7 toxin and the human muscarinic M1 receptor in its free and N-methylscopolamine-occupied statesQ27652082
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective AntagonistQ27666030
Comparative protein modelling by satisfaction of spatial restraintsQ27860866
Identification of G protein-coupled receptor genes from the human genome sequenceQ28202262
GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor functionQ28254935
Discovering high-affinity ligands for proteins: SAR by NMRQ29617569
Seven-transmembrane receptorsQ29619896
Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single moleculesQ30493203
Data-driven docking for the study of biomolecular complexesQ30980755
Data-driven docking: HADDOCK's adventures in CAPRI.Q30992986
Docking of antizyme to ornithine decarboxylase and antizyme inhibitor using experimental mutant and double-mutant cycle dataQ33451459
Recent progress in fragment-based lead discoveryQ33455221
Evolution of protein binding modes in homooligomersQ33618229
Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.Q33719668
Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.Q46016726
Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptorsQ46699162
Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.Q46913704
Allosteric small molecules unveil a role of an extracellular E2/transmembrane helix 7 junction for G protein-coupled receptor activationQ46985701
A dissection of specific and non-specific protein-protein interfacesQ47737233
Identification and molecular characterization of m3 muscarinic receptor dimersQ48177207
Crystallographic refinement by knowledge-based exploration of complex energy landscapes.Q48549817
Energetics of protein-protein interactions: analysis of the barnase-barstar interface by single mutations and double mutant cycles.Q49187978
Identification of a novel pharmacophore for peptide toxins interacting with K+ channels.Q50664253
A structure refinement method based on molecular dynamics in four spatial dimensions.Q52386873
Spatial localization of the K+ channel selectivity filter by mutant cycle-based structure analysis.Q52546897
CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsQ53340989
Complementarity of Structure Ensembles in Protein-Protein BindingQ57815055
Critical Role for the Second Extracellular Loop in the Binding of Both Orthosteric and Allosteric G Protein-coupled Receptor LigandsQ57838214
Stable allosteric binding of m1-toxin to m1 muscarinic receptorsQ72665997
Dissecting protein-protein recognition sitesQ77926233
On the dynamic nature of the transition state for protein-protein association as determined by double-mutant cycle analysis and simulationQ80461475
Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativityQ83206375
Energetic and structural interactions between delta-dendrotoxin and a voltage-gated potassium channelQ33891879
Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible dockingQ33949253
Flexible protein-protein dockingQ33993623
Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptorQ34017212
Structure of the BgK-Kv1.1 complex based on distance restraints identified by double mutant cycles. Molecular basis for convergent evolution of Kv1 channel blockersQ34140443
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitorsQ34175711
Monomeric G-protein-coupled receptor as a functional unitQ34431199
Target validation of G-protein coupled receptorsQ34525952
Assembly reflects evolution of protein complexesQ34787237
Heavier-than-air flying machines are impossible.Q35757370
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G proteinQ35778121
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues.Q36422842
Toxin insights into nicotinic acetylcholine receptorsQ36485022
Emergence of symmetry in homooligomeric biological assemblies.Q36945073
Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functionsQ37098373
Muscarinic toxins: tools for the study of the pharmacological and functional properties of muscarinic receptorsQ37490228
Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.Q37547722
Bioinformatics and molecular modelling approaches to GPCR oligomerization.Q37656672
Structural biology in fragment-based drug designQ37752790
Homomeric protein complexes: evolution and assemblyQ37775639
A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraintsQ38315995
Pirenzepine promotes the dimerization of muscarinic M1 receptors through a three-step binding processQ39849760
A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.Q39947679
Quantitative analysis of muscarinic acetylcholine receptor homo- and heterodimerization in live cells: regulation of receptor down-regulation by heterodimerizationQ40337775
A variable residue in the pore of Kv1 channels is critical for the high affinity of blockers from sea anemones and scorpionsQ40423398
Muscarinic toxin 7 selectivity is dictated by extracellular receptor loops.Q40479466
Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cellsQ40620568
Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.Q42277559
Building macromolecular assemblies by information-driven docking: introducing the HADDOCK multibody docking serverQ42427876
Lack of evidence for AT1R/B2R heterodimerization in COS-7, HEK293, and NIH3T3 cells: how common is the AT1R/B2R heterodimer?Q42806160
Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors.Q42844842
Influence of MT7 toxin on the oligomerization state of the M1 muscarinic receptor.Q43156439
Inhibition of acetylcholine muscarinic M(1) receptor function by the M(1)-selective ligand muscarinic toxin 7 (MT-7).Q43264495
Chemical synthesis of MT1 and MT7 muscarinic toxins: critical role of Arg-34 in their interaction with M1 muscarinic receptor.Q44253596
Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-oQ44483391
Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptorsQ44483424
Biophysics: is rhodopsin dimeric in native retinal rods?Q44645841
The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structureQ45029374
Conserved structural determinants in three-fingered protein domainsQ45106348
Design of tRNA(Lys)3 ligands: fragment evolution and linker selection guided by NMR spectroscopyQ45328799
P433issue36
P407language of work or nameEnglishQ1860
P921main subjectcell biologyQ7141
G protein-coupled receptorQ38173
P304page(s)31661-75
P577publication date2011-09-09
P1433published inJournal of Biological ChemistryQ867727
P1476titleStructural model of ligand-G protein-coupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor
P478volume286

Reverse relations

cites work (P2860)
Q27675253Conopeptide  -TIA Defines a New Allosteric Site on the Extracellular Surface of the  1B-Adrenoceptor
Q27678423Crystallization of recombinant green mamba ρ-Da1a toxin during a lyophilization procedure and its structure determination
Q35860873Distinct Agonist Regulation of Muscarinic Acetylcholine M2-M3 Heteromers and Their Corresponding Homomers
Q21134520Engineering of three-finger fold toxins creates ligands with original pharmacological profiles for muscarinic and adrenergic receptors
Q43479740High-throughput production of two disulphide-bridge toxins.
Q47788379Interpreting the structural mechanism of action for MT7 and human muscarinic acetylcholine receptor 1 complex by modeling protein-protein interaction
Q39765332Molecular conversion of muscarinic acetylcholine receptor M(5) to muscarinic toxin 7 (MT7)-binding protein.
Q37608542Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptor.
Q47348671Opportunities and Challenges in the Discovery of Allosteric Modulators of GPCRs
Q34918713Orthosteric binding of ρ-Da1a, a natural peptide of snake venom interacting selectively with the α1A-adrenoceptor
Q29871448Secreted Isoform of Human Lynx1 (SLURP-2): Spatial Structure and Pharmacology of Interactions with Different Types of Acetylcholine Receptors
Q40660620Structural Insight into Specificity of Interactions between Nonconventional Three-finger Weak Toxin from Naja kaouthia (WTX) and Muscarinic Acetylcholine Receptors
Q97535797Structure and selectivity engineering of the M1 muscarinic receptor toxin complex
Q47234473The Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review
Q28547175The Repellent DEET Potentiates Carbamate Effects via Insect Muscarinic Receptor Interactions: An Alternative Strategy to Control Insect Vector-Borne Diseases
Q36935273The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization
Q38741858The three-finger toxin fold: a multifunctional structural scaffold able to modulate cholinergic functions.

Search more.